These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16728216)

  • 1. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial.
    Bhadriraju S; Ray KK; DeFranco AC; Barber K; Bhadriraju P; Murphy SA; Morrow DA; McCabe CH; Gibson CM; Cannon CP; Braunwald E
    Am J Cardiol; 2006 Jun; 97(11):1573-7. PubMed ID: 16728216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
    Ray KK; Cannon CP; Morrow DA; Kirtane AJ; Buros J; Rifai N; McCabe CH; Gibson CM; Braunwald E
    Eur Heart J; 2007 Apr; 28(7):806-13. PubMed ID: 17403721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.
    Kirtane AJ; Leder DM; Waikar SS; Chertow GM; Ray KK; Pinto DS; Karmpaliotis D; Burger AJ; Murphy SA; Cannon CP; Braunwald E; Gibson CM;
    J Am Coll Cardiol; 2005 Jun; 45(11):1781-6. PubMed ID: 15936606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.
    Ndrepepa G; Mehilli J; Schulz S; Iijima R; Keta D; Byrne RA; Pache J; Seyfarth M; Schömig A; Kastrati A
    J Am Coll Cardiol; 2008 Aug; 52(7):512-7. PubMed ID: 18687242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
    Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W
    Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of admission glucose level on long-term prognosis in patients with acute coronary syndrome].
    Macín SM; Perna ER; Coronel ML; Kriskovich JO; Bayol PA; Franciosi VA; Riera-Stival JL; González-Arjol B; Badaracco JR
    Rev Esp Cardiol; 2006 Dec; 59(12):1268-75. PubMed ID: 17194422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era.
    Meisinger C; Hörmann A; Heier M; Kuch B; Löwel H
    Int J Cardiol; 2006 Nov; 113(2):229-35. PubMed ID: 16359742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome.
    Latchamsetty R; Fang J; Kline-Rogers E; Mukherjee D; Otten RF; LaBounty TM; Emery MS; Eagle KA; Froehlich JB
    Am J Cardiol; 2007 Apr; 99(7):939-42. PubMed ID: 17398188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function.
    Aronson D; Hammerman H; Kapeliovich MR; Suleiman A; Agmon Y; Beyar R; Markiewicz W; Suleiman M
    Diabetes Care; 2007 Apr; 30(4):960-6. PubMed ID: 17392556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.
    Steinberg BA; Moghbeli N; Buros J; Ruda M; Parkhomenko A; Raju BS; García-Castillo A; Janion M; Nicolau JC; Fox KA; Morrow DA; Gibson CM; Antman EM
    Am Heart J; 2007 Jul; 154(1):54-61. PubMed ID: 17584551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction.
    Aronson D; Hammerman H; Suleiman M; Markiewicz W
    Am J Cardiol; 2009 Oct; 104(8):1013-7. PubMed ID: 19801016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.